ANI Pharmaceuticals, Inc. (ANIP) Q2 FY25 Earnings Call

Q2 FY25 results, source: company transcript and SEC filings
QuarterQ2 FY25
Call date2025-08-08
Length66 minutes
EPS$1.38
EPS consensus$1.02
Revenue$211.4M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q4 FY25

All ANIP earnings ยท Back to ANIP overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.